XML 17 R4.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Income Statement [Abstract]        
Net product sales $ 1,562,860 $ 832,100 $ 3,504,636 $ 1,712,275
Operating expenses:        
Cost of goods sold $ 34,908 $ 89,775 $ 142,855 $ 180,310
Cost, Product and Service [Extensible List] us-gaap:ProductMember us-gaap:ProductMember us-gaap:ProductMember us-gaap:ProductMember
Research and development   $ 40,388 $ 159,347 $ 273,582
Selling, general and administrative $ 3,131,389 2,614,488 8,745,407 7,334,738
Total operating expenses 3,166,297 2,744,651 9,047,609 7,788,630
Loss from operations (1,603,437) (1,912,551) (5,542,973) (6,076,355)
Other income (expense):        
Interest income 35,558 24,714 112,052 29,419
Interest expense (126,028) (126,027) (373,973) (373,973)
Total other (expense) (90,470) (101,313) (261,921) (344,554)
Net loss $ (1,693,907) $ (2,013,864) $ (5,804,894) $ (6,420,909)
Net loss per share of common stock, basic $ (0.51) $ (0.60) $ (1.74) $ (2.09)
Net loss per share of common stock, diluted $ (0.51) $ (0.60) $ (1.74) $ (2.09)
Weighted-average shares used to compute basic net loss per share 3,343,070 3,343,070 3,343,070 3,077,145
Weighted-average shares used to compute diluted net loss per share 3,343,070 3,343,070 3,343,070 3,077,145